A published meta-analysis for BRCA1-related tumors reported a worse outcome among the breast cancer patients carrying a mutated BRCA gene [7], while BRCA1 mutated ovarian cancer patients had a more favorable clinical outcome [9]. The gene discussed is BRCA1; the disease is breast cancer.